Skip to main content

Table 1 Agreement in Metastatic Assay outcome between the development and alternative platforms

From: Analytical validation of a prognostic prostate cancer gene expression assay using formalin fixed paraffin embedded tissue

  Alternative Platform (Xcel™ Array)
Assay Positive Assay Negative Total
Development Platform (Prostate DSA™) Assay Positive 33 3 36
Assay Negative 1 38 39
Total 34 41 75
  1. Abbreviations: DSA = disease specific array